{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:45Z","timestamp":1788514725713,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clim.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T13:25:06Z","timestamp":1434288306000},"page":"349-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial"],"prefix":"10.1016","volume":"160","author":[{"given":"Hossein","family":"Esmaeilzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Aryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Arshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Bemanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Fallahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.05.012_bb0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2009.06.027","article-title":"Its impact on asthma study G, unmet needs in severe chronic upper airway disease (SCUAD)","volume":"124","author":"Bousquet","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/erv.13.45","article-title":"Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications","volume":"12","author":"Aryan","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.clim.2015.05.012_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1081-1206(10)60615-1","article-title":"Pathogenesis, diagnosis, and treatment of aspirin intolerance","volume":"99","author":"Jenneck","year":"2007","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2500\/ajra.2015.29.4154","article-title":"HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease","volume":"29","author":"Esmaeilzadeh","year":"2015","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Ding D, Dursun AB, Woessner KM, Simon RA, Stevenson DD, Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","article-title":"Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease","volume":"119","author":"Lee","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","article-title":"Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300mg aspirin daily","volume":"63","author":"Rozsasi","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/cea.12096","article-title":"Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD","volume":"43","author":"Choi","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2004.10.051","article-title":"Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis","volume":"115","author":"Corrigan","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/90667","article-title":"Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen","volume":"2","author":"Akbari","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2500\/aap.2014.35.3726","article-title":"Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease","volume":"35","author":"Aksu","year":"2014","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clim.2015.05.012_bb0065","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10753-013-9699-7","article-title":"Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease","volume":"36","author":"Aktas","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.clim.2015.05.012_bb0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1398-9995.2009.01989.x","article-title":"Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis","volume":"64","author":"Kim","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2010.08.037","article-title":"Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?","volume":"126","author":"White","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0085","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps","author":"Fokkens","year":"2012","journal-title":"Rhinol. Suppl."},{"key":"10.1016\/j.clim.2015.05.012_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2015.05.012_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/ajra.2014.28.4034","article-title":"Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors","volume":"28","author":"Nabavi","year":"2014","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin Desensitization Joint Task F, Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.clim.2015.05.012_bb0110","first-page":"183","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"10.1016\/j.clim.2015.05.012_bb0115","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12269","article-title":"Aspirin 300mg\/day is effective for treating aspirin-exacerbated respiratory disease","volume":"68","author":"Comert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/all.12131","article-title":"Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease","volume":"68","author":"Fruth","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2015.05.012_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2014.02.041","article-title":"Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study","volume":"134","author":"Swierczynska-Krepa","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0140","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2015.05.012_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2008.09.008","article-title":"Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca(2+) influx","volume":"131","author":"Togo","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/clim.2001.5021","article-title":"Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors","volume":"99","author":"Le","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/clim.1999.4795","article-title":"The safety and efficacy of ALLERVAX CAT in cat allergic patients","volume":"93","author":"Maguire","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.05.012_bb0160","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2015.05.012_bb0165","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.05.012_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.aller.2013.06.007","article-title":"Increased level of interleukin-13, but not interleukin-4 and interferon-gamma in chronic rhinosinusitis with nasal polyps","volume":"42","author":"Nabavi","year":"2014","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"10.1016\/j.clim.2015.05.012_bb0175","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2500\/aap.2007.28.3052","article-title":"Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"28","author":"Shome","year":"2007","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clim.2015.05.012_bb0180","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin-10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"Grimbaldeston","year":"2007","journal-title":"Nat. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T15:59:07Z","timestamp":1537545547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1521661615001862"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.05.012","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}